List of insiders holdings for Spyre Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Alspaugh Jonathan President and CFO | 2023-06-30 16:34:47 | 19,787,969 0 | 19,787,969 | Form 4 |
| Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 2024-04-25 16:55:38 | 0 5,176,222 | 5,176,222 | Form 4 |
| Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner | 2024-04-25 16:40:00 | 4,508,579 0 | 4,508,579 | Form 13D |
| Lilly Ventures Fund I LLC Shanafelt Armen Torres S. Edward 10% Owner | 2021-02-12 16:59:33 | 2,568,543 0 | 2,568,543 | Form 13G |
| LILLY ELI & CO Lilly Ventures Fund I LLC Shanafelt Armen 10% Owner | 2021-02-12 16:59:33 | 2,568,543 0 | 2,568,543 | Form 13G |
| Lawton Alison Frances Director | 2023-06-30 16:30:12 | 1,950,000 0 | 1,950,000 | Form 4 |
| Smith Hunter C Director | 2023-06-30 16:31:16 | 1,950,000 0 | 1,950,000 | Form 4 |
| Magovcevic-Liebisch Ivana Director | 2023-06-30 16:32:34 | 1,950,000 0 | 1,950,000 | Form 4 |
| Cox Russell J. Director | 2023-06-30 16:33:37 | 1,950,000 0 | 1,950,000 | Form 4 |
| Goldberg Jeff Marc President and CEO | 2022-12-01 20:47:37 | 1,884,838 0 | 1,884,838 | Form 4 |
| ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC ISALY SAMUEL D 10% Owner | 2023-02-14 16:01:11 | 1,797,221 0 | 1,797,221 | Form 13G |
| Quinn Anthony G. President & CEO | 2022-03-18 06:46:58 | 550,540 266,295 | 816,835 | Form 4 |
| Turtle Cameron Chief Executive Officer | 2024-02-20 21:21:33 | 746,907 0 | 746,907 | Form 4 |
| Novartis Bioventures Ltd NOVARTIS AG 10% Owner | 2020-01-30 16:12:04 | 617,769 0 | 617,769 | Form 13G |
| Neuman Linda L Chief Medical Officer | 2023-02-24 18:25:30 | 550,000 0 | 550,000 | Form 4 |
| Kastenmayer James Paul General Counsel | 2023-02-24 18:24:11 | 500,000 0 | 500,000 | Form 4 |
| Hanley Jr. Michael Conick Chief Business Officer | 2023-02-24 18:22:20 | 500,000 0 | 500,000 | Form 4 |
| Sloan Sheldon Chief Medical Officer | 2024-10-01 18:34:26 | 400,000 0 | 400,000 | Form 4 |
| Rojas-Caro Sandra Chief Medical Officer | 2016-05-19 16:37:04 | 200,000 0 | 200,000 | Form 4 |
| GEORGIOU GEORGE Director | 2018-08-15 16:40:25 | 192,528 0 | 192,528 | Form 4 |
| Lowe David George CEO and President | 2017-03-22 16:53:40 | 160,000 0 | 160,000 | Form 4 |
| Sloan Leslie Chief Operating Officer | 2022-08-25 19:36:17 | 130,000 0 | 130,000 | Form 4 |
| York Charles N II Chief Financial Officer and VP | 2020-02-19 17:15:29 | 126,000 0 | 126,000 | Form 4 |
| Burrows Scott L Chief Financial Officer | 2024-09-05 16:04:14 | 116,422 0 | 116,422 | Form 4 |
| Souza Marcio Director | 2022-08-25 19:37:05 | 90,000 0 | 90,000 | Form 4 |
| King-Jones Heidy See Remarks | 2024-02-02 20:23:54 | 63,000 0 | 63,000 | Form 4 |
| Schuchart Aaron Chief Business Officer | 2019-03-01 17:09:04 | 60,000 0 | 60,000 | Form 4 |
| Wooldridge James Chief Medical Officer | 2019-03-01 17:09:49 | 50,200 0 | 50,200 | Form 4 |
| Shanafelt Armen Director | 2022-06-09 21:22:33 | 43,000 0 | 43,000 | Form 4 |
| LAWLIS V BRYAN Director | 2022-06-09 21:15:38 | 43,000 0 | 43,000 | Form 4 |
| Mahatme Sandesh Director | 2022-06-09 21:18:44 | 43,000 0 | 43,000 | Form 4 |
| McKenna Mark C. Director | 2024-02-05 17:29:40 | 40,000 0 | 40,000 | Form 4 |
| Hebel Henry VP, Product Development | 2017-03-22 16:52:59 | 38,200 0 | 38,200 | Form 4 |
| Weber Steven VP, Controller&Princ Acctg Off | 2022-02-22 16:55:42 | 30,000 0 | 30,000 | Form 4 |
| Bruhn Suzanne Louise Director | 2020-06-10 16:21:57 | 28,100 0 | 28,100 | Form 4 |
| Albers Jeffrey W. Director | 2024-11-08 16:53:52 | 0 27,360 | 27,360 | Form 4 |
| TYLER JOSEPH E VP, Manufacturing | 2017-08-24 18:03:31 | 25,000 0 | 25,000 | Form 4 |
| Rowlinson Scott W VP, Research | 2017-08-24 18:02:15 | 25,000 0 | 25,000 | Form 4 |
| Rao Madduri Ravin Chief Medical Officer | 2020-02-19 17:14:05 | 25,000 0 | 25,000 | Form 4 |
| Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 2024-05-16 16:10:28 | 0 22,646 | 22,646 | Form 4 |
| Milligan Sandra Director | 2024-05-16 16:10:27 | 21,980 0 | 21,980 | Form 4 |
| HENDERSON MICHAEL THOMAS Director | 2024-05-16 16:10:12 | 11,323 0 | 11,323 | Form 4 |
| Stelzer Laurie Director | 2024-05-16 16:10:16 | 11,323 0 | 11,323 | Form 4 |
| BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 2024-02-14 16:21:51 | 0 0 | 0 | Form 13G |
| Brownstein Sara Director | 2021-02-25 19:30:36 | 0 0 | 0 | Form 3 |